NAFLD

This study tested whether a 12-week treatment with the medication semaglutide works better than an active diet program for teenage girls with obesity and PCOS. The main goal was to see which approach more effectively reduces dangerous fat in the liver and improves how the body us…

This study tested whether a drug called elobixibat could help adults with fatty liver disease (NAFLD or NASH). Forty-seven participants were randomly assigned to receive either the drug or a placebo for 16 weeks. Researchers measured changes in liver fat, cholesterol levels, and …

This small pilot study tested whether a drug called ibutamoren could reduce fat buildup in the livers of people with nonalcoholic fatty liver disease (NAFLD). Researchers enrolled 12 generally healthy adults with NAFLD to take the drug for 6 months. The main goal was to see if li…

This study tested whether a combination of two drugs, dasatinib and quercetin, could reduce liver scarring (fibrosis) in people with fatty liver disease. Thirty adults with confirmed liver scarring participated in this early-stage trial. The goal was to see if clearing certain ag…

This study tested whether the drug efinopegdutide could help adults with nonalcoholic steatohepatitis (NASH), a serious form of fatty liver disease. Researchers compared the drug against a placebo in 381 participants over 52 weeks to see if it could clear liver inflammation witho…

This study aimed to find better, non-invasive ways to check for liver damage in people with fatty liver disease (NAFLD). Researchers enrolled 1,005 patients across France to compare new blood tests and special scans against the standard liver biopsy. The goal was to develop tools…

This study tested new MRI scanning technology designed specifically for children. Current liver scans require patients to hold their breath, which is very difficult for kids and infants. The research aimed to develop 'free-breathing' MRI methods to make liver disease diagnosis mo…

This study aimed to see if two simple blood tests (called eLIFT and FibroMeter) could accurately screen for advanced liver scarring (fibrosis) in people with type 2 diabetes. It involved 722 participants with type 2 diabetes and a higher body weight. The results of the blood test…

This study aimed to understand the connection between fatty liver disease (NAFLD) and the risk of heart disease. Researchers examined 292 patients with NAFLD to see if the amount of scarring in their liver was linked to their risk for heart problems. They used non-invasive scans …

This study aimed to understand the financial and personal impact of non-alcoholic fatty liver disease (NAFLD) in Belgium. Researchers surveyed 73 adult patients with NAFLD to calculate their healthcare expenses and measure how the disease affected their quality of life. The goal …

This study aimed to understand how common and severe fatty liver disease is in people with type 2 diabetes. Researchers followed 317 patients from Swedish primary care clinics for three years, using advanced scans to measure liver fat and scarring. The goal was to learn which pat…